Holdings (Monthly)
Guide ↗
ProShares Ultra Health Care
· ProShares Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | ProShares GENIUS Money Market ETF | 74350P691 | Feb 2026 | 100,000 | $10.0M | 10.73% | — |
| 2 | Eli Lilly & Co. | 532457108 | Feb 2026 | 9,065 | $9.5M | 10.22% | EC |
| 3 | Johnson & Johnson | 478160104 | Feb 2026 | 27,507 | $6.8M | 7.32% | EC |
| 4 | AbbVie, Inc. | 00287Y109 | Feb 2026 | 20,173 | $4.7M | 5.02% | EC |
| 5 | Merck & Co., Inc. | 58933Y105 | Feb 2026 | 28,330 | $3.5M | 3.76% | EC |
| 6 | UnitedHealth Group, Inc. | 91324P102 | Feb 2026 | 10,341 | $3.0M | 3.25% | EC |
| 7 | Amgen, Inc. | 031162100 | Feb 2026 | 6,147 | $2.4M | 2.56% | EC |
| 8 | Abbott Laboratories | 002824100 | Feb 2026 | 19,848 | $2.3M | 2.48% | EC |
| 9 | Thermo Fisher Scientific, Inc. | 883556102 | Feb 2026 | 4,288 | $2.2M | 2.40% | EC |
| 10 | Gilead Sciences, Inc. | 375558103 | Feb 2026 | 14,161 | $2.1M | 2.26% | EC |
| 11 | Intuitive Surgical, Inc. | 46120E602 | Feb 2026 | 4,048 | $2.0M | 2.18% | EC |
| 12 | N/A | N/A | Feb 2026 | 11,075 | $1.8M | 1.93% | DE |
| 13 | Pfizer, Inc. | 717081103 | Feb 2026 | 64,898 | $1.8M | 1.92% | EC |
| 14 | Stryker Corp. | 863667101 | Feb 2026 | 3,928 | $1.5M | 1.63% | EC |
| 15 | Danaher Corp. | 235851102 | Feb 2026 | 7,176 | $1.5M | 1.62% | EC |
| 16 | Bristol-Myers Squibb Co. | 110122108 | Feb 2026 | 23,236 | $1.4M | 1.55% | EC |
| 17 | Vertex Pharmaceuticals, Inc. | 92532F100 | Feb 2026 | 2,897 | $1.4M | 1.54% | EC |
| 18 | Medtronic plc | N/A | Feb 2026 | 14,641 | $1.4M | 1.53% | EC |
| 19 | Repurchase Agreement | 000000000 | Feb 2026 | 1,422,502 | $1.4M | 1.52% | RA |
| 20 | McKesson Corp. | 58155Q103 | Feb 2026 | 1,409 | $1.4M | 1.49% | EC |
| 21 | Boston Scientific Corp. | 101137107 | Feb 2026 | 16,921 | $1.3M | 1.39% | EC |
| 22 | CVS Health Corp. | 126650100 | Feb 2026 | 14,489 | $1.2M | 1.24% | EC |
| 23 | HCA Healthcare, Inc. | 40412C101 | Feb 2026 | 1,823 | $966K | 1.04% | EC |
| 24 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 1,151 | $900K | 0.96% | EC |
| 25 | Cigna Group (The) | 125523100 | Feb 2026 | 3,049 | $884K | 0.95% | EC |
| 26 | N/A | N/A | Feb 2026 | 18,800 | $874K | 0.94% | DE |
| 27 | Cencora, Inc. | 03073E105 | Feb 2026 | 2,213 | $824K | 0.88% | EC |
| 28 | Elevance Health, Inc. | 036752103 | Feb 2026 | 2,536 | $812K | 0.87% | EC |
| 29 | N/A | N/A | Feb 2026 | 7,700 | $784K | 0.84% | DE |
| 30 | Repurchase Agreement | 000000000 | Feb 2026 | 704,945 | $705K | 0.76% | RA |
| 31 | Repurchase Agreement | 000000000 | Feb 2026 | 704,945 | $705K | 0.76% | RA |
| 32 | Zoetis, Inc. | 98978V103 | Feb 2026 | 5,030 | $659K | 0.71% | EC |
| 33 | Cardinal Health, Inc. | 14149Y108 | Feb 2026 | 2,712 | $622K | 0.67% | EC |
| 34 | IDEXX Laboratories, Inc. | 45168D104 | Feb 2026 | 912 | $599K | 0.64% | EC |
| 35 | Becton Dickinson & Co. | 075887109 | Feb 2026 | 3,271 | $577K | 0.62% | EC |
| 36 | Edwards Lifesciences Corp. | 28176E108 | Feb 2026 | 6,623 | $573K | 0.61% | EC |
| 37 | N/A | N/A | Feb 2026 | 28,090 | $570K | 0.61% | DE |
| 38 | N/A | N/A | Feb 2026 | 5,547 | $486K | 0.52% | DE |
| 39 | GE HealthCare Technologies, Inc. | 36266G107 | Feb 2026 | 5,200 | $438K | 0.47% | EC |
| 40 | ResMed, Inc. | 761152107 | Feb 2026 | 1,666 | $427K | 0.46% | EC |
| 41 | Repurchase Agreement | 000000000 | Feb 2026 | 422,967 | $423K | 0.45% | RA |
| 42 | Repurchase Agreement | 000000000 | Feb 2026 | 422,967 | $423K | 0.45% | RA |
| 43 | Agilent Technologies, Inc. | 00846U101 | Feb 2026 | 3,236 | $393K | 0.42% | EC |
| 44 | Waters Corp. | 941848103 | Feb 2026 | 1,121 | $358K | 0.38% | EC |
| 45 | Repurchase Agreement | 000000000 | Feb 2026 | 352,473 | $352K | 0.38% | RA |
| 46 | IQVIA Holdings, Inc. | 46266C105 | Feb 2026 | 1,944 | $348K | 0.37% | EC |
| 47 | DexCom, Inc. | 252131107 | Feb 2026 | 4,455 | $327K | 0.35% | EC |
| 48 | Biogen, Inc. | 09062X103 | Feb 2026 | 1,674 | $321K | 0.34% | EC |
| 49 | Mettler-Toledo International, Inc. | 592688105 | Feb 2026 | 233 | $318K | 0.34% | EC |
| 50 | STERIS plc | N/A | Feb 2026 | 1,120 | $283K | 0.30% | EC |
| 51 | Repurchase Agreement | 000000000 | Feb 2026 | 281,978 | $282K | 0.30% | RA |
| 52 | Repurchase Agreement | 000000000 | Feb 2026 | 281,978 | $282K | 0.30% | RA |
| 53 | Labcorp Holdings, Inc. | 504922105 | Feb 2026 | 946 | $274K | 0.29% | EC |
| 54 | Quest Diagnostics, Inc. | 74834L100 | Feb 2026 | 1,270 | $269K | 0.29% | EC |
| 55 | Humana, Inc. | 444859102 | Feb 2026 | 1,376 | $262K | 0.28% | EC |
| 56 | Centene Corp. | 15135B101 | Feb 2026 | 5,329 | $239K | 0.26% | EC |
| 57 | Zimmer Biomet Holdings, Inc. | 98956P102 | Feb 2026 | 2,262 | $223K | 0.24% | EC |
| 58 | Moderna, Inc. | 60770K107 | Feb 2026 | 3,968 | $213K | 0.23% | EC |
| 59 | West Pharmaceutical Services, Inc. | 955306105 | Feb 2026 | 821 | $209K | 0.22% | EC |
| 60 | Insulet Corp. | 45784P101 | Feb 2026 | 802 | $198K | 0.21% | EC |
| 61 | Viatris, Inc. | 92556V106 | Feb 2026 | 13,141 | $196K | 0.21% | EC |
| 62 | Hologic, Inc. | 436440101 | Feb 2026 | 2,540 | $191K | 0.21% | EC |
| 63 | Incyte Corp. | 45337C102 | Feb 2026 | 1,883 | $191K | 0.20% | EC |
| 64 | Cooper Cos., Inc. (The) | 216648501 | Feb 2026 | 2,270 | $190K | 0.20% | EC |
| 65 | Align Technology, Inc. | 016255101 | Feb 2026 | 762 | $145K | 0.16% | EC |
| 66 | Repurchase Agreement | 000000000 | Feb 2026 | 140,989 | $141K | 0.15% | RA |
| 67 | Universal Health Services, Inc. | 913903100 | Feb 2026 | 631 | $130K | 0.14% | EC |
| 68 | Revvity, Inc. | 714046109 | Feb 2026 | 1,294 | $127K | 0.14% | EC |
| 69 | Solventum Corp. | 83444M101 | Feb 2026 | 1,682 | $125K | 0.13% | EC |
| 70 | Baxter International, Inc. | 071813109 | Feb 2026 | 5,867 | $120K | 0.13% | EC |
| 71 | Bio-Techne Corp. | 09073M104 | Feb 2026 | 1,779 | $105K | 0.11% | EC |
| 72 | Charles River Laboratories International, Inc. | 159864107 | Feb 2026 | 561 | $100K | 0.11% | EC |
| 73 | Henry Schein, Inc. | 806407102 | Feb 2026 | 1,142 | $94K | 0.10% | EC |
| 74 | Molina Healthcare, Inc. | 60855R100 | Feb 2026 | 586 | $90K | 0.10% | EC |
| 75 | INVESCO GOVT AND AGCY LEX | 825252885 | Feb 2026 | 67,200 | $67K | 0.07% | STIV |
| 76 | DaVita, Inc. | 23918K108 | Feb 2026 | 403 | $63K | 0.07% | EC |
| 77 | N/A | N/A | Feb 2026 | 1,435 | $-2663993 | -2.86% | DE |